|
⚲
|
| Keyboard |
| Hurvitz Chaim
✚
|
|
|---|---|
| CIK # | 0001630542 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001630542] | |
| 4 | [0001630542] | |
| SC 13G | [0001630542] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Hurvitz Chaim | Galmed Pharmaceuticals Ltd | [2015-01-13] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Hurvitz Chaim | |
| Novint Technologies Inc | |
| NRX Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Novint Technologies Inc DROR
Stock Option (Right to Buy) · derivative
|
2024-06-17 | Grant | 21,122,239 | $0.00 | |
|
NRX Pharmaceuticals Inc NRXP
Common Stock, par value $0.001 per share
|
2023-08-30 | Buy | 70,000 | $0.29 | 20,300 |
|
Novint Technologies Inc DROR
Series A Convertible Preferred Stock · derivative
|
2023-08-14 | Grant | 592,150.79 | ||
|
Novint Technologies Inc DROR
Common Warrants · derivative
|
2023-08-14 | Grant | 42,417,309 | ||
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2022-11-18 | Buy | 40,408 | $1.10 | 44,449 |
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2022-11-17 | Buy | 171,780 | $1.08 | 185,522 |
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2022-11-16 | Buy | 287,812 | $0.99 | 284,934 |
|
NRX Pharmaceuticals Inc NRXP
Employee Stock Option · derivative
|
2022-10-21 | Grant | 162,660 | ||
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2021-05-24 | Grant | 1,436,350 | ||
|
NRX Pharmaceuticals Inc NRXP
Common Stock Warrant (Right to buy) · derivative
|
2021-05-24 | Grant | 218,423 | ||
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2021-05-24 | Grant | 208,443 |